What is the current share price of Gland Pharma Limited (GLAND)?

As of the latest market update, Gland Pharma Limited (GLAND) is trading at ₹2,262.2. The stock has moved 1.92% down in the recent session.

What is the technical sentiment for GLAND stock?

Based on our proprietary technical analysis, the current signal for GLAND is "BUY". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Gland Pharma Limited?

Gland Pharma Limited has seen a 52-week high of ₹2,396 and a 52-week low of ₹1,573.6. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Gland Pharma Limited belong to?

Gland Pharma Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of GLAND?

Gland Pharma Limited (GLAND) has a market capitalization of approximately ₹37.27K Cr. This classifies it as a small cap stock in the Indian market.

GLAND

NSE

Gland Pharma Limited (SMALL CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹2,262.20

44.30 (1.92%)

High VOLATILITY

As on 12 Jun 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹37.27K Cr

SMALL CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

37.0

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹1,573.6+43.8%

52W High₹2,396-5.6%

Current Price

₹2,262.20

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹1,809.76

Upper Circuit₹2,714.64

Reference Price

₹2,262.20

Investment Checklist

Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1951.2

Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹2000.4

Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

News: Honasa Consumer, 6 other stocks hit 52-week highs, rally up to 35% in a month...

EMA(9) Crossover: Price crossed below EMA(9): Fresh bearish weakness signal.

Technical Analysis

Analysis from 2026-06-12

Confidence

50%

Trend

BULLISH

Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

EMA20

2205.25

EMA50

2041.35

EMA200

1885.46

Price Action

MIXED

NEUTRAL

Higher Highs4

Higher Lows4

Lower Highs5

Lower Lows5

Support & Resistance Levels

Resistance (Above)

₹2396.00

Support (Below)

₹2196.00

₹2131.00

₹2074.00

₹2034.00

₹1991.45

Volume Analysis

TrendDECREASING

Change-55.50%

Unusual VolumeNo

Stop Loss Levels

Fixed Risk

1% Risk₹2239.58

3% Risk₹2194.33

5% Risk₹2149.09

7% Risk (Custom)

₹2103.85

Technical Levels

1x ATR (Volatility)₹2168.11

2x ATR (Swing)₹2074.02

3x ATR (Trend)₹1979.93

Immediate Support₹2196.00

Moving Averages

EMA 20 (Medium-term)₹2205.25

EMA 50 (Trend)₹2041.35

EMA 200 (Long-term)₹1885.46

Financials

Financial Analysis

Metric	Dec '24	Mar '25	Jun '25	Dec '25
Revenue	₹1,384.1 Cr	₹1,392 Cr	₹1,505.6 Cr	₹1,695.4 Cr
Net Profit	₹204.7 Cr	₹186.5 Cr	₹215.5 Cr	₹261.5 Cr
EPS	₹12.42	—	₹13.08	₹15.87
Operating Profit	₹418.4 Cr	₹386.9 Cr	₹425.3 Cr	₹473.7 Cr

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,807.70	+0.75%
DIVISLAB	Divi's Laboratories Limited	₹6,638.00	-0.26%
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,571.20	-0.02%
CIPLA	Cipla Limited	₹1,389.40	+0.44%
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,104.70	-0.11%
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,275.40	-0.05%
LUPIN	Lupin Limited	₹2,293.30	+0.88%
MANKIND	Mankind Pharma Limited	₹2,381.10	+0.35%
AUROPHARMA	Aurobindo Pharma Limited	₹1,472.80	+0.59%
LAURUSLABS	Laurus Labs Limited	₹1,394.30	+0.25%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
14 Aug 2025	Dividend - Rs 18 Per Share	DIVIDEND
16 Aug 2024	Annual General Meeting/Dividend - Rs 20 Per Share	AGM
06 Aug 2021	Annual General Meeting	AGM

Announcements

Latest updates

View All

Date	Description	Link
10 Jun 2026	Copy of Newspaper Publication
04 Jun 2026	Analysts/Institutional Investor Meet/Con. Call Updates
02 Jun 2026	Updates
29 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates
26 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
15 May 2026	Financial Results/Dividend
15 May 2026	Board Meeting Intimation	XBRL
28 Jan 2026	Board Meeting Intimation	XBRL
28 Jan 2026	Financial Results
03 Nov 2025	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for GLAND

View All

Honasa Consumer, 6 other stocks hit 52-week highs, rally up to 35% in a month

positive

ET Markets - Stocks 1d ago

Honasa Consumer, 6 other stocks hit 52-week highs, rally up to 35% in a month

Despite weakness in the broader market, seven BSE 500 stocks including Honasa Consumer, Aegis Logistics and Gland Pharma scaled fresh 52-week highs, gaining up to 35% over the past month amid strong investor buying.

AEGISLOGBSEBSE500IETFCONSUMERDIVIDENDGLANDHDFCBSE500HONASASJLOGISTICFast Moving Consumer GoodsFinancial Services

Read full story

Five Stocks To Buy: Adani Energy, Adani Green, Gland Pharma And More | June 08, 2026

positive

NDTV Profit 5d ago

Five Stocks To Buy: Adani Energy, Adani Green, Gland Pharma And More | June 08, 2026

Top picks include power transmission major Adani Energy Solutions, renewable energy giant Adani Green Energy, pharma player Gland Pharma, automotive major Ashok Leyland, and carbon materials manufacturer Himadri Speciality Chemical.

ADANIENSOLADANIENTADANIGREENADANIPOWERAGNIASHOKLEYCHEMICALDPELENERGYGKENERGYGLANDGREENPOWERGVPILHIGREENHSCLINOXGREENIREDAKPELKPIGREENNTPCGREENOMPOWERPARAGONSAATVIKGLSDL26BEESSERVOTECHSPECIALITYSWSOLARCapital GoodsChemicals

Read full story

positive

LiveMint - Markets 23d ago

Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?

The Nifty Pharma index has surged nearly 11% over the past month, significantly outperforming the Nifty 50, which declined 3.6% during the same period. On a year-to-date (YTD) basis, the Nifty Pharma index has gained 9.4%, while the benchmark Nifty 50 has fallen by an equal margin.

BANKIETFBIOCONEQUAL50ADDGILT10BETAGILT5BETAGILT5YBEESGLANDGSEC10IETFGSEC5IETFMON50EQUALNIFTY100EWPHARMABEESPVTBANIETFSDL26BEESTOP10ADDTOP15IETFTOP20Financial ServicesFINANCIAL SERVICES

Read full story

GLAND

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for GLAND

Honasa Consumer, 6 other stocks hit 52-week highs, rally up to 35% in a month

Five Stocks To Buy: Adani Energy, Adani Green, Gland Pharma And More | June 08, 2026

Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?

Frequently Asked Questions

What is the current share price of Gland Pharma Limited (GLAND)?

What is the technical sentiment for GLAND stock?

What is the 52-week high and low for Gland Pharma Limited?

Which sector does Gland Pharma Limited belong to?

What is the market capitalization of GLAND?